BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, May 14, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 5, 2014
View Archived Issues
Capstone Therapeutics reports phase Ia results for AEM-28
Read More
Infinity Pharmaceuticals and Roche to evaluate combinations of obinutuzumab and duvelisib
Read More
Mutation type and location correlates with enzymatic abnormalities
Read More
BARDA extends contract with Chimerix for brincidofovir for treatment of smallpox
Read More
BioLineRx initiates phase I study of BL-8040 for stem cell mobilization
Read More
Development and characterization of a novel anti-influenza preclinical candidate
Read More
Group in Thailand generates novel series of multivalent HIV-1 integrase inhibitors
Read More
Trinomia polypill increases adherence to cardiovascular treatments
Read More
Cynata Therapeutics initiates EMA scientific advice procedure for Cymerus
Read More
Bristol-Myers Squibb launches two antiviral agents in Japan
Read More
Researchers in Israel disclose novel phosphorylcholine conjugates for autoimmune disease
Read More
CUNY discloses new NO- and H2S-releasing NSAIDs
Read More
Novel EZH2 inhibitors disclosed by Constellation Pharmaceuticals for cancer
Read More
Russian group synthesizes new HCV NS5A inhibitors
Read More
New ROR gamma modulators reported by Aurigene
Read More
Levomepromazine proves safe and effective for the management of distressing NEMD in MPS III
Read More
Companies commit to accelerating vaccine program in response to Ebola crisis
Read More
FDA awards pembrolizumab accelerated approval for melanoma
Read More
FDA grants fast track status to Pulmaquin for non-cystic fibrosis bronchiectasis
Read More
Chimerix's brincidofovir shows in vitro activity against Ebola
Read More
Bayer submits MAA for Eylea in Japan for macular edema following BRVO
Read More
Launch of inhaled, once-daily combination treatment for COPD in Japan
Read More
Sanofi announces Japanese launch of Jevtana for prostate cancer
Read More
FDA gives NewLink Genetics approval to conduct phase I studies of Ebola vaccine
Read More
Mapp Biopharmaceutical signs HHS contract to accelerate development of ZMapp
Read More
Merck & Co.'s relebactam earns FDA QIDP designation
Read More
FDA grants QIDP designation to Debiopharm's Debio-1450
Read More